drugset / Trial / NCT07546214
A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis.
RandomizedParallel-groupSingle-blindTreatment
Summary
To demonstrate therapeutic equivalence and safety of Tapinarof Cream, 1% (Sun pharma Canada, Inc.) and Vtama® (Tapinarof) Cream, 1% in the treatment of plaque psoriasis.
Timeline
- Start
- 2025-10-13
- Primary completion
- 2026-03-18
- Completion
- 2026-03-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tapinarof | Other / unclassified | 1 % | Topical |